SYNERGIE GENE+ OUTCOMES
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98055817
- Registration number
- 7645616
- Mark type
- Stylized text
- Filed
- 23 Jun 2023
- Published for opposition
- 30 Jan 2024
- Registered
- 07 Jan 2025
- Attorney of record
- Patricia I. Reding
Goods and services
- Class 035 — Advertising and business services: Administering discount group purchasing programs, namely, facilitating and negotiating gene therapy outcomes-based contracts with pharmaceutical manufacturers that require longitudinal patient tracking to assess therapy efficacy and durability, and value-based warranty payments to a risk pool to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or service
Owner
- Synergie Medication Collective, LLC, Wilmington, DE, US
- Synergie Medication Collective, LLC, Wilmington, DE, US
- Synergie Medication Collective, LLC, Wilmington, DE, US
Prosecution history
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Sept 2024 — USE AMENDMENT FILED
- 16 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 26 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jan 2024 — PUBLISHED FOR OPPOSITION
- 10 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE